Metagenomi, Inc. Common Stock
Biotechnology
Healthcare
MGX
37.02 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.34
52 week high
4.19
high
2.34
52 week low
0.00
low
2.18
growth
-11.02 %
previous Close
2.34
P/E ratio
market cap
70.28 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
20.59 %
eps surprise
25.00 %
net profit margin
0.00 %
606.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top